AzTrials
AzTrials

Exercise MetabolismGlucose oxNCT07646665

Exogenous Carbohydrate Oxidation During High Intensity Exercise

A study testing glucose in people with Exercise Metabolism, run by University of Bath at 1 site in United Kingdom.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The aim of the current project is to assess exogenous glucose oxidation rates during exercise at moderate and high intensity. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Exercise Metabolism
What is being tested?
glucose
Could I receive a placebo?
No, everyone receives an active treatment
How many people
6 participants
Where
1 siteUnited Kingdom
Study dates
8 Jun 2026to 30 Sep 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Endurance trained
  • Aged 18 to 65 years

Who cannot join

  • Contraindications to exercise
  • Unable to complete 2 hours of continuous cycling

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • University of Bath

    Bath, BA2 7AY

Other trials in United Kingdom

About this study

The aim of the current project is to assess exogenous glucose oxidation rates during exercise at moderate and high intensity.

Being tested
glucose

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • glucoseOther

    Glucose ingestion at 90 g/h labelled with U13C glucose

Study groups in NCT07646665
Study groupRoleWhat they receive
GlucoseExperimentalGlucose ingestion during exercise at 90 g.h labelled with U13C glucose.
Receives: Other: glucose

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total exogenous glucose oxidation rate

    Total exogenous glucose oxidation rate (g/h)

    Measured: Measured over 120 mins

Secondary outcomes (2)
  1. Exogenous glucose oxidation rate during moderate intensity exercise

    Exogenous glucose oxidation rate during moderate intensity exercise (g/h)

    Measured: 90 minutes

  2. Exogenous glucose oxidation rate during high intensity exercise

    Exogenous glucose oxidation rate during high intensity exercise (g/h)

    Measured: 30 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jun 2026
  2. Study start8 Jun 2026
  3. Primary completion30 Jul 2026 (estimated)
  4. Study completion30 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
6 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07646665
Sponsor's protocol ID
16515-20228
Acronym
Glucose ox
Status last verified
Jul 2026
First submitted
9 Jun 2026
Last updated
8 Jul 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing glucose in people with Exercise Metabolism, run by University of Bath at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 8 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total exogenous glucose oxidation rate (time frame: Measured over 120 mins). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in